Denali Therapeutics To Host Webcast Highlighting Presentations on Enzyme TransportVehicle™ Programs at the 2026 WORLDSymposium™

Core Viewpoint - Denali Therapeutics Inc. is set to showcase its Enzyme TransportVehicle™ (ETV) programs at the 22nd Annual WORLDSymposium™, highlighting the potential of ETV in delivering enzyme replacement therapies throughout the body, including the brain [1]. Company Overview - Denali Therapeutics Inc. is a biotechnology company focused on developing biotherapeutics that can cross the blood-brain barrier using its proprietary TransportVehicle™ platform [2]. - The company has a clinically validated delivery platform and a diverse portfolio of therapeutic candidates at various stages of development, aiming to provide effective treatments for neurodegenerative diseases, lysosomal storage disorders, and other serious conditions [2].